Key result
Multiple arterial grafting is linked to ~16% lower late mortality vs single arterial grafting in elderly patients.
Why the study?
Multiple arterial grafting remains infrequently used, especially in elderly patients, leading to this evaluation of age-related outcomes of multiple versus single arterial grafting.
Does multiple arterial grafting reduce all-cause late mortality in adult patients undergoing primary isolated CABG compared to single arterial grafting?
Cohort (n=69,624)
Yes
Does multiple arterial grafting reduce all-cause late mortality in adult patients undergoing primary isolated CABG compared to single arterial grafting?
Hazard Ratio: 0.84 (95% CI 0.79–0.88)
p-value: p=<0.001
Multiple arterial grafting offers a long-term survival benefit over single arterial grafting in both younger and elderly patients undergoing CABG.
Supports MAG consideration in elderly CABG patients; extends observational data but leaves randomized confirmation open.
Multiple arterial grafting (MAG) utilizes more than one arterial graft with any additional grafts being saphenous vein grafts (SVG). It remains an infrequently used coronary surgical revascularization technique, especially in elderly patients. Our study aims to evaluate the age-related association with the relative outcomes of multiple versus single arterial grafting (SAG). The Australian and New Zealand national registry was used to identify adult patients undergoing primary isolated CABG with at least two grafts. Exclusion criteria included reoperations, concomitant or previous cardiac surgery, and the absence of arterial grafting. Propensity score matching was used to match patient groups. The primary outcome was all-cause late mortality and the secondary outcomes were 30-day mortality and 30-day hospital readmission. We selected 69,624 eligible patients with a mean (standard deviation) age of 65.0 (10.2) years old. Matching between MAG and SAG generated 16,882 pairs of patients < 70 years old and 10,921 pairs of patients ≥ 70 years old. At a median [interquartile range] follow-up duration of 5.9 [3.2–9.6] years, MAG was associated with significantly reduced mortality compared to SAG (hazard ratio [HR], 0.73; 95% confidence interval [CI], 0.68–0.78; p < 0.001) in the younger subgroup as well as the elderly subgroup (HR, 0.84; 95% CI, 0.79–0.88; p < 0.001). In conclusion, MAG offers a survival benefit over SAG, in both younger and elderly patients.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2023) conducted a cohort in Coronary artery disease requiring primary isolated CABG (n=69,624). Multiple arterial grafting (MAG) vs. Single arterial grafting (SAG) was evaluated on All-cause late mortality (HR 0.84, 95% CI 0.79-0.88, p=<0.001). Multiple arterial grafting significantly reduced long-term all-cause mortality compared to single arterial grafting in elderly patients aged 70 years or older (HR 0.84).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: